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Abstract - The objective of this research was to evaluate the relationship of Ki-67 and telomerase expression with the pro-
gression of cervical intraepithelial neoplasia (CIN) and the physical state of the DNA of high-risk human papillomavirus 
(HR-HPV) types. A comparative study was done on 80 biopsies of human (female) cervical tissue, distributed in the fol-
lowing manner: 20 CIN-negative biopsies and 60 CIN-positive biopsies of varying grades. The detection of the proteins 
Ki-67 and telomerase was performed through immunohistochemistry; the detection of HR-HPV, by in situ hybridization. 
The expression of Ki-67 and telomerase increased with the progression of the CIN lesion (p <0.001). The HR-HPV genome 
was detected in 75% of the cases with CIN, as well as in 20% of the tissues without histological lesions (p=0.001). A sig-
nificant association was found between the increase in telomerase and Ki-67 expression and the integration of the DNA of 
HR-HPV. The overexpression of Ki-67, telomerase and the presence the integration of the DNA of HR-HPV are evidenced 
by more aggressive lesions that may progress to invasive carcinoma.
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INTRODUCTION
Invasive cervical carcinoma is preceded by prema-
lignant  lesions  (cervical  intraepithelial  neoplasia 
or CIN), which originate in the squamocolumnar 
transformation  zone.  These  lesions  may  progress 
to cancer when this area presents a high-risk HPV 
(HR-HPV) viral genome, the most frequent types of 
which are 16, 18, 31, 33, and 45, among others. At 
present it is thought that the integration of HR-HPV 
DNA with the genome of the infected cell promotes 
the progression of CIN-1 lesions to CIN-2, CIN-3 
and/or invasive carcinoma. In situ hybridization is 
a method that allows for the determination of the 
presence of HR-HPV, as well as for the integration 
of the DNA of these viruses into the cellular genome, 
and its association with the progression of cervical 
lesions, thus supporting clinical diagnosis (Kalof and 
Cooper, 2006; Evans and Cooper, 2004).
On the other hand, despite histopathological ex-
amination being the traditional method utilized to 
confirm the presence of a cervical lesion, false nega-
tive results for CIN have increased due to diagnostic 
variation among observers (Heatley, 2002), as a result 
of which the utility of different biomarkers to assist 82 ARIANNA VEGA-PEÑA ET AL.
in the diagnosis of early lesions is being evaluated. 
The nuclear antigen Ki-67 (MIB-1 being its com-
monly used monoclonal antibody) is evidenced in 
all active phases of the cellular cycle, except in the G0 
phase, and is utilized as a good indicator of cellular 
proliferation (Scholzen and Gerdes, 2000; Cheung et 
al., 2004; Yang et al., 2006).
The oncoprotein E7 of HR-HPV promotes cellu-
lar proliferation upon joining in action with the pro-
tein Rb, increasing the kinetics of the cellular cycle 
and the overexpression of Ki-67 (Doorbar, 2006).
Telomerase is an enzyme that has as a function 
the replacement of nucleotide sequences that are re-
moved from the telomeric ends of the chromosomes 
in each replication. Telomerase consists of two subu-
nits: human telomerase RNA (hTR) and telomerase 
reverse transcriptase (hTERT). hTERT has a catalytic 
function in the replication of the ends of lineal DNA. 
In cancer or cellular lines of cancer, an increase in 
the activity of telomerase in comparison with pre-
malignant lesions and lesionless cells has been found 
(Smith et al., 2004; Bravaccini et al., 2005).
Studies have been performed to determine the 
physical state of the HR-HPV DNA of HR-HPVs. In 
this respect, Cooper et al. (1991) demonstrated that 
the punctate pattern observed in the nucleus repre-
sented the integrated version of the virus in the cel-
lular genome, while the diffuse pattern corresponds 
to the episomal state of the viral DNA. In cervical 
lesions, the relationship of the expression of the pro-
teins Ki-67 and telomerase with the physical state of 
the HR-HPV DNA is still not clear. The aim of this 
study was to evaluate the relationship of the expres-
sion of Ki-67 and telomerase as well as the physical 
state of HR-HPV DNA with the progression of CIN.
MATERIALS AND METHODS
Research design and specimens
A cross-sectional comparative study was done on 80 
biopsies of cervical tissue in paraffin from women 
who  attended  the  dysplasia  clinic  of  the  Mexican 
Institute of Social Insurance’s (IMSS) General Re-
gional Hospital No 1 in Acapulco, Guerrero, Mexico. 
Of these samples, 15 had a histological diagnosis of 
CIN-1, 15 of CIN-2 and 30 of CIN-3. Included in the 
study as controls were 20 biopsies of cervical tissue 
without evidence of CIN, which were obtained from 
women who had undergone hysterectomies because 
of uterine fibroids. Only women who freely decided 
to participate and signed a letter of informed con-
sent were included in the study. This project was ap-
proved by the Institutional Committee for Bioethics 
of the University of Guerrero.
Immunohistochemistry for Ki-67 and hTERT
From each sample, 4 to 5 slices of tissue 3 microns 
in thickness were obtained. To evaluate the expres-
sion of Ki-67 and hTERT, the monoclonal antibod-
ies MIB-1 (Dako, Carpinteria, CA, USA) and 2C4 
(Novus Biologicals, Littleton, CO, USA) were used 
respectively  with  the  Cytoscan  HRP/DAB  immu-
nohistochemical system of detection (Cell Marque 
Corporation, Hot Springs, AR, USA [now relocated 
to Rocklin, CA, USA]). The histological slices were 
deparaffinized and placed in a solution of immun-
oDNA  Retriever  (BioSB,  Inc.,  Santa  Barbara,  CA, 
USA).  Later,  the  primary  antibody,  previously  di-
luted in accordance with the manufacturer’s instruc-
tions, was added; the chromogen diaminobenzidine 
was added; and finally, the specimens were stained 
with Mayer’s hematoxylin (Merck, USA).
For positive controls, slices of squamous cell car-
cinoma with overexpression of Ki-67 were utilized as 
well as slices of mammary carcinoma with overex-
pression of hTERT. These same tissues, without the 
addition of the primary antibody, were used as nega-
tive controls.
Evaluation of the expression of Ki-67 and hTERT
The expression in the tissues was evaluated in ac-
cordance to the distribution and localization of the 
positive reaction within the cell and within the depth 
of the epithelium. The expression of Ki-67 was con-
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dent in the nucleus of the cells: for hTERT, when the 
coloration was present in the nucleus or both the nu-
cleus and cytoplasm. In respect to the layers of the 
epithelium,  the  reaction  was  classified  as  negative 
when the immunostaining was located solely in the 
deep basal or parabasal cells of the cervix; as a slight 
positive when the lower third of the cervical epitheli-
um showed coloration; as a moderate positive, when 
the coloration was localized in the lower two-thirds 
of the epithelium, and as a high positive when the 
coloration was located throughout the thickness of 
the epithelium (Syrjanen, 2005).
In situ hybridization with amplification 
with tyramide
The detection of the viral genome by in situ hybridi-
zation was accomplished with the GenPoint™ system 
of  tyramide  signal  amplification  (Deko,  Caprinte-
ria, CA, USA). The cervical tissue slices were placed 
on silanized microscope slides, deparaffinized, and 
subjected to enzymatic digestion with proteinase K. 
Later, the probe of biotinylated viral DNA was added 
for the detection of high-risk viral types: 16, 18, 31, 
33, 35, 39, 45, 51, 52, 56, 58, 59 and 68. The slices 
were denaturalized and subjected to hybridization 
for 20 h (hybridizer, Dako, Carpinteria, CA, USA). 
Later, an astringent solution was added as well as pri-
mary streptavidin peroxidase. Biotinyl-tyramide and 
secondary streptavidin were added. Finally, the chro-
mogen diaminobenzidine (DAB) was added and the 
samples stained with Mayer’s hematoxylin (Merck, 
USA). The positive reaction was visualized within 
the nucleus with a dark brown color. The pattern of 
the obtained signal was classified as diffuse or punc-
tate, as previously described by Kalof et al. (2005).
Cervical squamous cell carcinoma tissue and a 
culture of SiHa cells, both with HPV-16, served as 
positive controls.
Statistical analysis
For the comparison of the frequencies, Fisher’s exact 
test was used. Models of multinomial logistic regres-
sion were evaluated to determine the relationship of 
the expression of Ki-67 and telomerase with the pro-
gression of the cervical lesions and the physical state 
of the DNA of the HR-HPV. The statistical analysis 
was  performed  with  the  software  STATA  version 
9.2.
RESULTS
Expression of Ki-67 and hTERT
The expression of Ki-67 in the tissues without CIN 
was localized solely in some parabasal cells (Fig. 1A) 
while in the tissues with lesions; this expression was 
visualized solely in the cells histologically altered by 
the lesion. In addition, the expression of Ki-67 in-
creased with the progression of the CIN, spreading 
from a localization in the lower third in CIN-1 to the 
entire thickness of the epithelium in CIN-3 (Fig. 1A-
B) (p <0.001). The expression of hTERT, similar to 
that of Ki-67, increased with the progression of CIN 
(Table 1). The highest expression of Ki-67 (56.7%) 
and hTERT (63.3%) was encountered (p<0.001) in 
the group of women who exhibited CIN-3 lesions. 
In these cases, the reaction was located throughout 
the depth of the epithelium and restricted to the his-
tologically altered area of the tissue (Fig. 2A-B). On 
the other hand, the expression of hTERT was found 
in the lower third of the epithelium in 20% of the 
women without lesions (Table 1).
HR-HPV and the physical state of the virus
Of the women analyzed, 61.2% were positive for HR-
HPV, with CIN-2 (80%) and CIN-3 (83.3%) cases 
showing greater frequencies. The punctate pattern of 
HR-HPV was seen in all CIN groups, being more fre-
quent in CIN-3 (88%) (Fig. 3B). In 20% (4 cases) of 
the tissues without histological lesions, the presence 
of HR-HPV was found, 2 with the punctate signal 
pattern and 2 with a diffuse signal (Fig. 3A, Table 2).
The association of the expression of Ki-67 and hTERT 
with the physical state of HR-HPV
The expression and localization of Ki-67 was signifi-
cantly associated with the presence of HR-HPV when 84 ARIANNA VEGA-PEÑA ET AL.
Fig. 1. Expression of Ki-67 (20X). A) Normal cervical tissue showing nuclear immunostaining in some cells, basal and parabasal; B) 
CIN 1 showing nuclear immunoreactivity in 1/3 lower of epithelium; C) CIN 3 showing strong immunostaining of Ki-67 in the entire 
epithelial thickness.Biomarkers for cervical neoplasia and Hpv 85
Fig. 2. Expression of telomerase (20X). A) Immunostaining in some cells basal and parabasal of normal cervical tissue; B) CIN 1 show-
ing nuclear immunostaining for telomerase in the 1/3 lower of the epithelium; C) CIN III showing strong nuclear immunostaining of 
telomerase.86 ARIANNA VEGA-PEÑA ET AL.
Ki-67 was expressed and localized within the lower 
two-thirds of the epithelium (OR=17.5; p<0.01) as 
well as up to the total depth of the epithelium (OR=37; 
p<0.001) (Table 3). This association was still greater 
when the HR-HPV DNA showed a virus-integrated 
pattern (punctate signal) and was located within the 
lower 2/3 of the epithelium (OR=21.9; p=0.001) as 
well as throughout the total strata of the epithelium 
(OR=64.1; p<0.001) (Table 4). A similar trend was 
manifested by the overexpression of hTERT which 
was significantly associated with the integrated state 
of HR-HPV when it was located in the lower third of 
the epithelium (OR=10.7; p<0.049) and in the lower 
two-thirds of the epithelium (OR=50.2; 0=0.001), as 
well as throughout the total depth of the epithelium 
(OR=50.1; p=0.001) (Table 4).
DISCUSSION
The treatment of patients with precursory lesions of 
the uterine cervix depends upon the histological di-
agnosis. This diagnosis, although reliable in the ma-
Fig. 3. DNA signal high risk HPV (40 X). A) CIN 1 showing signal diffuse in superficial epithelial cells (arrow); B) Cervical intraepithe-
lial neoplasia 3 with punctate signal in the nuclei of cells (arrow).
Table 1. Expression of Ki-67 and hTERT by histological diagnosis
Histological diagnosis
Location in the epithelium No CIN
(%) n
CIN 1
(%) n
CIN 2
(%) n
CIN 3
 (%) n
p value*
Ki-67 expression
Negative (100) 20 0 0 0 <0.001
lower 1/3  0 (80.0) 12 (6.7) 1 0
lower 2/3  0 (20.0) 3  (93.3) 14 (43.3) 13
Full thickness 0 0 0 (56.7) 17
hTERT expression
Negative (80) 16 0 0 0 <0.001
lower 1/3  (20) 4 (73.3) 11 (6.7) 1 0
lower 2/3  0 (26.7) 4 (80.0) 12 (36.7) 11
Full thickness 0 0 (13.3) 2 (63.3) 19
* Fisher exact test. P<0.001, test for trend for both markers. CIN: Cervical intraepithelial neoplasia. BIOMARkERS FOR CERVICAl NEOplASIA AND HpV 87
Table 2. HR-HPV and physical state of virus by histological diagnosis.
Histological diagnosis
TOTAL
(%) n
No CIN
(%) n
CIN 1
(%) n
CIN 2
(%) n
CIN 3
(%) n
p value*
HR-HPV
Negative (38.8) 31 (80.0) 16 (46.7) 7 (20.0) 3 (16.7) 5 <0.001
Positive (61.2) 49 (20.0) 4 (53.3) 8  (80.0)12 (83.3) 25
Signal pattern HR-HPV
Diffuse (24.5) 12 (50.0) 2 (25.0) 2 (41.7) 5 (12.0) 3 0.194
Punctuate  (75.5) 37 (50.0) 2 (75.0) 6 (58.3) 7 (88.0) 22
* Fisher exact test. CIN: Cervical intraepithelial neoplasia. 
Table 3. Association between Ki-67 and hTERT expression with HR-VPH
HR-HPV
Location in the epithelium Negative
 (%) n
Positive
(%) n
OR (95%CI) p value
Ki-67
Negative (51.5) 16 (8.2) 4 1.0*
Lower 1/3  (22.6) 7 (12.2) 6 4.2 (0.8-21.3) 0.083
Lower 2/3  (19.4) 6  (49.0) 24 17.5 (4.0-77.0) <0.001
Full thickness (6.5) 2 (30.6) 15 37.0 (5.5-250.0) <0.001
hTERT
Negative (45.1) 14 (4.0) 2 1.0*
Lower 1/3  (22.6) 7 (18.4) 9 12.4 (1.8-85.1) 0.011
Lower 2/3  (19.4) 6 (42.9) 21 31.5 (4.8-204.6) <0.001
Full thickness (12.9) 4  (34.7) 17 35.9 (5.0-254.9) <0.001
Multinomial regression model adjusted for age. CI: Confidence interval. * Reference category,
Table 4. Association between Ki-67 and hTERT expression with the physical state of HR-HPV,
HR-HpV
Location in the
epithelium
Negative
(%) n
Diffuse
(%) n
OR (95%CI) p value
Punctuate
(%) n
OR (95%CI) p value
Ki-67
Negative (51.5)16 (16.7) 2 1.0*  (5.4) 2 1.0*
Lower 1/3  (22.6) 7 (16.7)2 3.3 (0.3-33.0) 0.310 (10.8) 4 5.0 (0.7-34.5) 0.106
Lower 2/3  (19.4) 6 (66.6) 8 12.0 (1.7-85.9) 0.013 (43.2) 16 21.9 (3.8-127.1) 0.001
Full thickness (6.5) 2 0 10.0 (0.4 - ∞) 0.160  (40.5) 15 64.1 (7.8-524.9) <0.001
hTERT
Negative (45.2)14 (7.7) 1 1.0* (2.7) 1 1.0*
Lower 1/3  (22.6) 7 (30.7) 4 13.3 (0.9-188.5) 0.056  (13.5) 5 10.7 (1.0-113.3) 0.049
Lower 2/3  (16.1) 5 (38.5) 5 19.4 (1.4-268.8) 0.027 (46.0) 17 50.2 (5.2-489.3) 0.001
Full thickness (16.1) 5 (23.1) 2 11.9 (0.8-189.7) 0.079 (37.8) 14 50.1 (4.9-512.0) 0.001
Multinomial regression model adjusted for age. CI: Confidence interval. * Reference category88 ARIANNA VEGA-PEÑA ET AL.
jority of the cases, depends on the quality and accu-
racy of the CIN diagnosis, as well as on an adequate 
interpretation  of  the  benign  reactive  changes  that 
may be confused with a CIN. The joint evaluation of 
the histology and some biomarkers, as those used in 
this work, may be complementary helpers in the di-
agnosis and prognosis of a lesion. In four specimens 
of tissue without CIN we encountered the presence 
of HR-HPV. Two of these specimens showed a punc-
tate signal pattern and the expression of telomerase 
localized in the lower third of the epithelium, indi-
cating an evident alteration of the cellular cycle, pos-
sibly due to the integration of the HR-HPV DNA 
into the cellular genome, with a high probability of 
these women showing a CIN within a short time 
(Mittal et al., 1993; Kruse et al., 2001; Pirog et al., 
2002). This observation will be checked by following 
these women closely.
We found a significant association between the 
increase in the expression of Ki-67 and the progres-
sion of CIN. This overexpression correlated with the 
integration of the HR-HPV DNA into the cellular 
genome. This correlation confirms that the determi-
nation of Ki-67, upon being a marker of cellular pro-
liferation, is useful in the detection of early lesions 
that emerge through the interaction of the HR-HPV 
oncoproteins E6 and E7 with the genome of infected 
cells, corroborating the discoveries already described 
in other studies (Agoff et al., 2003; Bahnassy et al., 
2006).
In a manner similar to Ki-67, the increased ex-
pression of hTERT is associated significantly with 
CIN progression; similar results have been obtained 
by Frost et al. (2000) and Keating et al. (2001). These 
researchers found high levels of hTERT expression in 
cases of CIN-3 and squamous cell carcinoma (SCC). 
Nowak (2000) observed the expression of telomerase 
in 66% of high-grade lesions and in 100% of cervi-
cal carcinomas, suggesting that this marker may be 
important in the diagnosis and prognosis of invasive 
carcinoma. He thus proposes that the overexpression 
of the telomerase may be a useful indicator in the ear-
ly detection of cervical carcinoma. In our study, we 
encountered telomerase expression in CIN-1 lesions, 
including from the lower first third to the lower two-
thirds of the epithelium. It was also expressed in the 
4 cases negative for CIN but positive for HR-HPV. 
Although there were, of course, only four cases with 
such characteristics, these results indicated to us that 
the telomerase may be a good marker for incipient 
infections by HR-HPV.
We also encountered the overexpression of te-
lomerase in CIN of high grade, in the presence of 
HR-HPV  integrated  DNA.  This  indicates  that  the 
oncoproteins E6 and E7 of these viruses cooperate 
to promote a proliferative state and cellular immor-
talization through telomerase activation (Shay and 
Bacchetti, 1997; Munger et al., 2004; Liu et al., 2008; 
Bellon and Nicot, 2008).
The result that 25% of the cases with CIN were 
HR-HPV negative may be because the probe used 
does not include all the HPV considered as likely 
high risk, such as types 53 and 66. HPV-56 and 66 
have been detected by our workgroup in women in 
the south of Mexico (State of Guerrero) in speci-
mens with CIN-negative cytologies: 0.7% of these 
specimens had HPV-53 and 0.06% HPV-66 while 
in the cases with low-grade squamous intraepithe-
lial lesions (LSIL), 1.7% exhibited HPV-53 and 1.1%, 
HPV-66 (Illades-Aguiar et al., 2010). These results 
are why it is suggested that the probe should contain 
these VPH types.
On the other hand, upon correlating the expres-
sion of Ki-67 and/or telomerase with HR-HPV infec-
tion, a significant association of the expression of Ki-
67 and telomerase with HR-HPV was found when 
this expression is localized in the lower two-thirds or 
the entirety of the epithelium’s thickness. These re-
sults suggest that the expression of telomerase and/
or cellular proliferation is associated with cervical 
carcinogenesis, being markers important and useful 
for appraising the progression of a cervical lesion. 
Cheung et al. (2004) described how the determina-
tion of Ki-67, telomerase and chromosomal in situ 
hybridization are methods that permit the detection 
of cancerous and precancerous cells, and thus they 
may be used as markers of these lesions.BIOMARkERS FOR CERVICAl NEOplASIA AND HpV 89
The  integration  of  the  viral  genome  into  the 
cellular genome is a key event for the development 
and  progression  of  CIN.  Few  studies  have  been 
done  where  the  physical  state  of  HR-HPV  DNA 
has been analyzed in cervical samples in paraffin. 
In our study, we found 75.5% of the CIN cases had 
a punctate signal pattern. Kalof et al. (2005) studied 
25 CIN-1 cases and 17 CIN-2 and CIN-3 cases, with 
the results of the punctate signal being detected only 
in 3 CIN-1 cases (13.6%) infected with HR-HPV 
and in 100% of the CIN-2 and CIN-3 cases similarly 
infected. Presently it is known that the integration 
of the HR-HPV DNA with the DNA of the host cell 
is visualized with a punctate pattern within the cel-
lular nucleus, while the expression of a diffuse sig-
nal in the nucleus of the infected cells is related to 
the episomal state of the virus, a productive pheno-
type of HPV, and koilocytic changes observed with 
greater frequency in low-grade lesions (Cooper et 
al., 2003). While the integration of the viral genome 
into the host cell is a common event in high-grade 
lesions, it is practically absent in low-grade lesions 
(CIN-1). In this study, the integrated state of the 
viral genome was present in 75% of the CIN-1 le-
sions  positive  for  HR-HPV,  indicating  that  these 
women show an early lesion that will surely evolve 
into high-grade one, where the significant associa-
tion of the overexpression of telomerase with the 
progression of the CIN and the integration of viral 
DNA suggests that the activation of telomerase is 
an event very early in cervical carcinogenesis which 
correlates with the presence of HR-HPV.
The cellular proliferation, evaluated by Ki-67 ex-
pression, in association with the overexpression of te-
lomerase and HR-HPV DNA integration in different 
grades of CIN indicate a high risk of progression into 
invasive carcinoma. The simultaneous assessment of 
these biomarkers in biopsies allows for detection of 
early and incipient lesions in underdeveloped coun-
tries such as ours, where cervical invasive carcinoma 
continues  being  one  of  the  principal  problems  of 
public health.
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